文献速递生殖医学

利用单细胞RNA测序和蛋白质-蛋白质相互作用网络识别精子发生障碍候选基因并预测ICSI结局

Identifying candidate genes for spermatogenic failure and predicting ICSI outcomes using single-cell RNA sequencing and protein-protein interaction networks.
PubMed 文献 · Hum Reprod · 2025-01-01

本研究整合单细胞RNA测序数据与蛋白质-蛋白质相互作用网络,结合机器学习算法构建基因优先级排序框架,识别出320个精子发生障碍候选基因,并在34例患者中预测ICSI结局,PRC-AUC为0.96(95%CI:0.89-1.00),ROC-AUC为0.82(95%CI:0.63-0.97)。全外显子组测序显示模型预测基因中可能致病性变异检出率从11.8%升至29.4%。

要点

  • 机器学习框架整合scRNA-seq与PPI网络,识别320个精子发生障碍候选基因。
  • 预测ICSI结局的PRC-AUC=0.96(95%CI:0.89-1.00),ROC-AUC=0.82(95%CI:0.63-0.97)。
  • 模型预测基因中可能致病性变异检出率从11.8%升至29.4%。

核心结论

  • 整合单细胞转录组与PPI网络的机器学习框架可高效识别精子发生障碍候选基因,并在预测ICSI结局方面达到较高精度(PRC-AUC=0.96,95%CI:0.89-1.00;ROC-AUC=0.82,95%CI:0.63-0.97)。

研究设计与样本

  • 研究结合健康人体组织的单细胞RNA测序数据(涵盖细胞类型和发育阶段特异性表达)与PPI网络训练预测模型,采用5折交叉验证、功能富集分析,并以34例精子发生障碍亚型(无精子症、弱精子症、畸形精子症)患者的外显子组测序和ICSI结局临床数据进行验证。

主要发现

  • 模型在精子发生障碍基因预测中表现稳健(PRC-AUC=0.88,95%CI:0.83-0.93;ROC-AUC=0.98,95%CI:0.96-0.99)。
  • 模型在亚型分类中表现良好,如畸形精子症(PRC-AUC=0.96,95%CI:0.91-0.99;ROC-AUC=0.94,95%CI:0.87-0.98)。
  • 模型预测ICSI结局的PRC-AUC=0.96(95%CI:0.89-1.00),ROC-AUC=0.82(95%CI:0.63-0.97)。
  • 患者样本外显子组测序显示,模型预测基因子集中可能致病性变异检出率从11.8%升至29.4%,临床结局与模型预测一致。

关键数值与推荐

  • 精子发生障碍基因预测:PRC-AUC=0.88(95%CI:0.83-0.93),ROC-AUC=0.98(95%CI:0.96-0.99)。
  • 畸形精子症亚型分类:PRC-AUC=0.96(95%CI:0.91-0.99),ROC-AUC=0.94(95%CI:0.87-0.98)。
  • ICSI结局预测:PRC-AUC=0.96(95%CI:0.89-1.00),ROC-AUC=0.82(95%CI:0.63-0.97)。
  • 模型预测基因子集中可能致病性变异检出率从11.8%升至29.4%。

临床怎么用

  • 作者认为该整合机器学习框架为揭示男性不育遗传因素和预测治疗结局提供了有力工具,为改进诊断策略和更明智的生殖医学临床决策铺平道路。

局限性

  • 模型局限性包括基于文献整理或数据库注释的基因标签进行训练,可能引入误分类或注释偏倚。
  • 缺乏实验验证以及外部队列规模与多样性有限,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How can integrating updated single-cell transcriptomics and protein-protein interactions (PPIs) with machine learning algorithms improve gene prioritization for spermatogenic failure and predict ICSI outcomes? SUMMARY ANSWER: A machine learning framework integrating single-cell RNA sequencing (scRNA-seq) and PPI networks efficiently identified 320 candidate genes for spermatogenic failure and achieved high precision in predicting ICSI outcomes (precision-recall (PRC)-AUC=0.96, 95% CI: 0.89-1.00; receiver operating characteristic (ROC)-AUC = 0.82, 95% CI: 0.63-0.97). WHAT IS KNOWN ALREADY: Over 100 genes are implicated in spermatogenic failure, yet patients with distinct genetic backgrounds exhibit highly variable ICSI outcomes. While machine learning-based gene prioritization offers potential for novel gene discovery, the existing methods rely on bulk RNA sequencing or lack multi-omics integration, limiting their ability to leverage single-cell resolution or predict clinical outcomes. STUDY DESIGN, SIZE, DURATION: This study combined scRNA-seq data (capturing cell type- and developmental stage-specific expression) from healthy human tissues with PPI networks to train predictive models. Validation included 5-fold cross-validation, functional enrichment analyses, and clinical data from whole-exome sequencing (WES) and ICSI outcomes in 34 patients with spermatogenic failure subtypes (azoospermia, asthenozoospermia, teratozoospermia). PARTICIPANTS/MATERIALS, SETTING, METHODS: Public datasets (Human Protein Atlas, STRING, Gene Expression Omnibus) provided scRNA-seq and PPI data. Node2Vec-derived PPI network embeddings and cell type- and developmental stage-specific expression features were used to train random forest classifiers. Gene Ontology, Mammalian Phenotype Ontology enrichment analyses, and WES of patient blood samples validated candidate genes and ICSI outcomes. MAIN RESULTS AND THE ROLE OF CHANCE: Our models demonstrated robust performance in spermatogenic failure gene prediction (PRC-AUC = 0.88, 95% CI: 0.83-0.93; ROC-AUC = 0.98, 95% CI: 0.96-0.99), subtype classification (e.g. teratozoospermia, PRC-AUC = 0.96, 95% CI: 0.91-0.99; ROC-AUC = 0.94, 95% CI: 0.87-0.98), and ICSI outcome prediction (PRC-AUC = 0.96, 95% CI: 0.89-1.00; ROC-AUC = 0.82, 95% CI: 0.63-0.97). WES of patient samples revealed an increased detection rate of likely causative variants among a subset of model-predicted genes, rising from 11.8% to 29.4%, with clinical outcomes aligning with model predictions. LIMITATIONS, REASONS FOR CAUTION: Model limitations include training on literature-curated or database-annotated gene labels, which may introduce misclassification or annotation bias. Additionally, the absence of experimental validation and the limited size and diversity of external cohorts necessitate further verification. WIDER IMPLICATIONS OF THE FINDINGS: This integrative machine learning framework provides a powerful tool for uncovering genetic contributors to male infertility and predicting treatment outcomes, paving the way for improved diagnostic strategies and more informed clinical decision-making in reproductive medicine. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (32370719, 32170667), the Shanghai Municipal Science and Technology Major Project (2017SHZDZX01), and the National Key Research and Development Program of China (2021YFC2301503). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Liu L, Huang S, Jiang F, et al. Identifying candidate genes for spermatogenic failure and predicting ICSI outcomes using single-cell RNA sequencing and protein-protein interaction networks. Hum Reprod. 2025. PMID: 41033661. doi:10.1093/humrep/deaf186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。